Breaking News, Promotions & Moves

Actylis Names Scott Thomson as CEO

Thomson offers a three-decade track record in the pharmaceutical and chemical industries.

Author Image

By: Charlie Sternberg

Associate Editor

Actylis, a global manufacturer and sourcing expert of critical materials and performance ingredients for the life sciences and specialty chemicals markets, has appointed Scott Thomson as Chief Executive Officer.   Thomson has a three-decade track record in the pharmaceutical and chemical industries, most recently as CEO of SPI Pharma, a global provider of pharmaceutical ingredients, systems and services, where he helped lead the sustainable improvement of its strategic development and executio...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters